Spoken Alpha
Warby Parker Inc.
Warby Parker designs and sells eyeglasses, sunglasses, contact lenses, and eye exams directly to consumers through an omnichannel platform combining e-commerce and 323 retail stores. The company manufactures frames in-house and offers prescription lenses starting at $95, along with premium lens options and telehealth vision services.
Warby Parker Inc is a Healthcare company operating in Medical Instruments & Supplies with a $3.18B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
19 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for WRBY.
$ curl https://api.spokenalpha.com/v1/companies/WRBYFAQ
Spoken Alpha indexes WRBY's earnings call transcripts at https://spokenalpha.com/companies/WRBY. Each call links to attributed speakers and parsed analyst Q&A. Warby Parker Inc.'s own investor relations page is at https://investors.warbyparker.com/overview/.
Warby Parker Inc. (WRBY) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
Warby Parker Inc. (WRBY) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $0.03 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $0.05 | $0.05 | 0.0% | $235.5M | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $0.11 | $0.11 | 0.0% | $242.4M | — | — | EODHD |
| Q4 FY2025 | 2026-02-25 | $-0.04 | $0.01 | -100.0% | $212.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $0.12 | $0.09 | +33.3% | $221.7M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $0.02 | $0.02 | 0.0% | $214.5M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $0.14 | $0.11 | +27.3% | $223.8M | — | — | EODHD |
| Q4 FY2024 | 2025-02-26 | $-0.06 | $0.03 | -100.0% | $190.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.06 | $0.05 | +20.0% | $192.4M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $0.08 | $0.05 | +60.0% | $188.2M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $0.11 | $0.07 | +57.1% | $200.0M | — | — | EODHD |
| Q4 FY2023 | 2024-02-27 | $-0.01 | $0.01 | -100.0% | $161.9M | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $0.01 | $0.01 | 0.0% | $169.8M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $0.04 | $0.02 | +100.0% | $166.1M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $0.06 | $0.04 | +50.0% | $172.0M | — | — | EODHD |
| Q4 FY2022 | 2023-02-27 | $-0.17 | $-0.00 | -100.0% | $146.5M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $0.01 | $0.01 | 0.0% | $148.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-0.01 | $-0.02 | +50.0% | $149.6M | — | — | EODHD |
| Q1 FY2022 | 2022-05-15 | $-0.04 | $-0.04 | 0.0% | $153.2M | — | — | EODHD |
| Q4 FY2021 | 2022-03-16 | $-0.08 | $-0.09 | +11.1% | $132.9M | — | — | EODHD |
Source: EODHD. WRBY reported actuals as published; sparse fields render as —.